The new agreement will allow Medable to integrate Withings home data collection technologies into its clinical trial software platform. (metamorworks/iStock/Getty Images Plus)
Trial software company Medable has teamed up with medical device developer Withings Health Solutions in a move to boost its decentralized learning business.
The deal — financial terms of which were not disclosed — will allow Medable to integrate Withings’ home data collection technologies into its clinical trial software platform. Medable CEO Michelle Longmire, MD, said the partnership will help the company reach patients and further expand its remote clinical trial business.
This sentiment was echoed by Antoine Robiliard, vice president of health solutions at Withings, who said Medable shares the company’s focus on improving the way trials are conducted and the patient experience.
Withings’ current portfolio of devices includes connected scales, blood pressure monitors, an advanced sleep system, a smart temporary thermometer, and a hybrid smartwatch.
The company, Withings’ “connected health” division, has had several months of busy negotiations. In March, it partnered with weight-loss metabolic health company Calibrate (PDF) and in June signed an agreement to operate electronic health records AthenaHealth (PDF).
Medable was also making alliances. In February, it partnered with CVS Health to gain access and participate in clinical trials at select MinuteClinics.
On the same day, Medable announced the acquisition of Leo Innovation, a Danish company Omhu, which develops skin tracking apps that allow patients to send photos for evaluation by dermatologists.